The North America Cancer Immunotherapy Market Size is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 11.7% from 2023 to 2033. Cancer immunotherapy, also known as immuno-oncology, is a type of treatment that uses the immune system to recognize, target, and eliminate cancer cells.